Naslov
PHARMACOGENETICS AND ANTIPSYCHOTICS IN THE LIGHT OF PERSONALIZED PHARMACOTHERAPY

Autori
Alma Mihaljević-Peleš1, Marina Šagud1, Nada Božina2, Maja Živković3 and Nikolina Jovanović1

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Program&Abstrac Book / Nema - Zagreb : Medicinska naklada, 2010, 55-55

Skup
12th Central European Neuropsychopharamacological Symposium - CENP

Mjesto i datum
Zagreb, Hrvatska, 07.05.2010. - 08.05.2010

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Nije recenziran

Ključne riječi
pharamacogenetics; antipsychotics; polymorphisms; isoenzymes P450

Sažetak
The concept of personalized drug therapy on the basis of genetic investigations has become a major issue in psychopharmacology. Pharmacogenetic studies have focused on polymorphisms in liver cytochrome P450 isoenzymes that metabolize many antidepressant and antipsychotic medications. The most significant results are the association between drug metabolic polymorphisms of cytochrome P450 with variations in drug metabolic rates and side effects. Additionally, polymorphisms in dopamine and serotonin receptor genes are repeatedly found associated with response phenotypes, probably reflecting the strong affinities that most antipsychotics display for these receptors. The contribution of kinetic factors to the clinical outcome of antipsychotic treatment has a strong evidence base. Genetic tests for the pretreatment prediction of antipsychotic response have obvious implications for the selection and improvement of antipsychotic treatment. The pretreatment determination of individual’s drug metabolic rates by CYP genotyping is the leading field. This review summarizes the present knowledge of associations between cytochrome P450 isoenzymes and the efficacy and side effects of antipsychotics.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA